Saxenda for Breastfeeding: Evidence, Eligibility, Coverage
The Saxenda label on breastfeeding: Whether it passes into human breast milk is not known.
- Active ingredient
- liraglutide
- How it is taken
- daily injection
Saxenda: key facts
Its half-life is about 13 hours. About half is gone by 13 h, and about 3% is still present once five half-lives have passed (2.7 d).
In SCALE, for Obesity and Prediabetes, 56 weeks, the result was 7.4% of body weight, against 3% for the placebo group.
Sources: FDA label (DailyMed).
Breastfeeding guidance in the label
| Medicine | What the label says |
|---|---|
| Whether it passes into human breast milk is not known. |
These details come from FDA labels: the DailyMed label.
These warnings are listed in the label: FDA DailyMed drug label.
Each GLP-1 label on breastfeeding
| Medicine | What the label says | How it is taken |
|---|---|---|
| Whether it passes into human breast milk is not known. | daily injection | |
| Whether it passes into human breast milk is not known. | weekly injection | |
| SNAC appears in breast milk and in the tablets. For the injection, whether it passes into breast milk is not known. | weekly injection or daily tablet | |
| The tablets have SNAC, and breast milk contains it too. | daily tablet | |
| Levels in breast milk were undetectable or low in one small study. | weekly injection | |
| Levels in breast milk were undetectable or low in one small study. | weekly injection | |
| Whether it passes into human breast milk is not known. | daily tablet | |
| Whether it passes into human breast milk is not known. | weekly injection | |
| Whether it passes into human breast milk is not known. | daily injection | |
| Byetta | Whether it passes into human breast milk is not known. | twice-daily injection |
Sources: FDA label (DailyMed).
Ask your prescriber these questions
- While I am breastfeeding, is there an option that has been studied more?
- Is it better to wait until I have weaned?
Read the full Saxenda prescribing information on DailyMed.